Last Updated on October 15, 2024 by The Health Master
Mumbai: Lupin Limited announced the launch of Sevelamer Hydrochloride Tablets, 800 mg, having received approval from the United States Food and Drug Administration (USFDA). The product will be manufactured at Lupin’s facility in Nagpur, India.
Sevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagel® Tablets, 800 mg of Genzyme Corporation.
Sevelamer Hydrochloride Tablets, 800 mg (RLD: Renagel) had estimated annual sales of $75 million in the US (IQVIA MAT December 2021).
USFDA approves this drug for bone marrow cancer treatment
USFDA gives nod to Unichem Laboratories for Divalproex Sodium
USFDA approves this drug for all heart patients to cut death, hospitalization risk
USFDA gives nod to Zydus to market Dapagliflozin tablets
USFDA gives nod to Strides Pharma for Amantadine HCL Softgel Capsules
USFDA gives nod to Lupin for sNDA for Solosec
Why these Pharma Companies are realigning their India operations
USFDA approves this drug for bone marrow cancer treatment
NDPS Exporters and Importers to register with ICEGATE portal: CBN
USFDA gives nod to Unichem Laboratories for Divalproex Sodium
20 projects worth Rs. 840 crore for PLI scheme for Bulk drugs
Drug recall: Aurobindo, Sun Pharma recall these products
CDSCO gives nod to Sun Pharma to conduct Phase 4 clinical…
Drug recall: Medical Device – Infusion Pumps recalled due to this reason
How Antibiotics polluting Indian rivers: Study
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
